Independent Directors Alone Don’t Make Committees Independent

Special committees handle billions in conflict transactions annually, yet most boards still confuse director independence with committee independence. The distinction matters more than most Nomination & Remuneration Committees recognise.

Director independence focuses on individual qualifications. Committee independence requires structural separation from the conflicted transaction’s decision-making apparatus. A director can meet every regulatory independence test while sitting on a committee that lacks functional independence from management or conflicted board members.

The mandate document typically receives insufficient attention. Boards often delegate “review and recommendation” authority without specifying the committee’s investigative powers, access to advisors, or decision-making timeline. Vague mandates create governance gaps that become visible only during disputes or regulatory scrutiny.

Documentation standards vary dramatically across special committees. Some maintain detailed meeting minutes and advisor correspondence. Others treat their work as informal consultation. The documentation gap becomes critical when committees must defend their process to minority shareholders, regulators, or courts reviewing transaction fairness.

Committee composition presents recurring challenges beyond independence requirements. Size matters—three members can move quickly but lack diverse expertise, while larger committees often struggle with coordination and confidentiality. The chair selection process frequently defaults to seniority rather than relevant transaction experience or stakeholder management skills.

Advisor selection reveals another structural weakness. Many committees inherit advisors pre-selected by management or conflicted directors. Independent advisor selection, with direct reporting lines to the committee rather than management, remains uncommon despite its importance for maintaining process integrity.

The timing of committee formation creates persistent problems. Early formation allows comprehensive transaction review but may complicate confidentiality and market disclosure obligations. Late formation limits review scope but simplifies regulatory compliance. Most boards choose late formation, which constrains the committee’s effectiveness.

Information access agreements between committees and management often receive minimal negotiation. Standard agreements may limit the committee’s access to sensitive competitive information, related-party transaction history, or management projections that inform transaction valuation. These limitations become binding constraints on committee effectiveness.

My Boardroom Takeaway

Directors considering special committee appointments should examine the committee’s structural independence, not just individual member independence. Key questions include: Does the committee control its advisor selection? Can it access all transaction-relevant information without management filters? Does the mandate specify investigative powers and decision criteria? Boards may wish to establish special committee protocols before conflicts arise, rather than designing process under transaction pressure.